Stimulants (2017) | Petros Levounis, MD

This presentation is part of the Addiction Medicine Review Course 2017, an overview of the core elements of addiction medicine, presented by top experts in the field. Together with the other presentation it can serve as a broad review for clinicians, a review of the basics for newcomers, or a starting point for those preparing to sit for the Board of Addiction Exam.

Target Audience

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
  • Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
  • Public health officials who want an understanding of the current state of addiction treatment
  • Non-physicians who are involved in the treatment of addiction

Learning Objectives

At the end of the talk the learners should be able to….

  1. Recognize signs and symptoms of stimulant intoxication and withdrawal syndromes.
  2. Contrast primary and secondary prevention.
  3. Discuss the connection between crystal methamphetamine use among gay men and risk of HIV transmission.
Course summary
Available credit: 
  • 1.00 AMA Category 1
  • 1.00 Attendance
Course opens: 
09/01/2017
Course expires: 
09/01/2020
Cost:
$50.00
Part of: 
Addiction Medicine Review Course (2017)
Rating: 
0

Petros Levounis, MD, MA
Dr. Levounis is professor and chair of Psychiatry at Rutgers New Jersey Medical School, and chief of service at University Hospital in Newark, New Jersey. Dr. Levounis came to Rutgers from Columbia University where he served as director of the Addiction Institute of New York and chief of addiction psychiatry at St. Luke's and Roosevelt Hospitals from 2002 to 2013.

Dr. Levounis has published twelve books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself”; the textbook of “Substance Dependence and Co-Occurring Psychiatric Disorders”; and the best-seller “Pocket Guide to Addiction Assessment and Treatment.” He is currently working on the second edition of his buprenorphine book, published by the American Psychiatric Association. Dr. Levounis’s books have been translated into Portuguese, Hungarian, and Japanese.

Disclosure

Dr. Levounis has no relevant financial relationships

The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

CSAM designates this edduring internet-based educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This credit may also be applied to the CMA Certification in Continuing Medical Education.

Available Credit

  • 1.00 AMA Category 1
  • 1.00 Attendance

Price

Cost:
$50.00
Please login or register to take this course.